Financial Social Media and Digital Communications for Small Caps

Joined December 2018
1,183 Photos and videos
#HVO @hVIVO_UK - Holding(s) in Company - Octopus Investments has increased its shareholding from 13.06%  to 14.4% (97,312,186 shares) novuscomms.com/2026/06/09/hv…
3
4
179
Novus Comms retweeted
#QHE - @quantum_helium - Sagebrush-1 Extended Production Test. Operational Update ✅ Extended production test continuing at Sagebrush-1 ✅ Initial acid injection programme successfully completed on the upper Leadville zone ✅ Technical analysis supports progression to the next phase of reservoir stimulation ✅ Planned fracture stimulation designed to enhance reservoir connectivity ✅ Preliminary analysis confirms raw gas produced has close similarities to gas analysis conducted in 1994 ✅ Further operational updates expected in due course CEO Howard McLaughlin: "...Importantly, the programme has generated exactly the type of reservoir data we set out to obtain. Every stage of testing has improved our understanding of the Leadville Formation and helped define the most effective path forward. The information gathered so far is helping us optimise the programme as we work towards evaluating the commercial potential of the Leadville Formation....” #helium #colorado read: londonstockexchange.com/news…
9
17
752
#HVO @hVIVO_UK Consultancy contract signed with Decoy Therapeutics ✅ Consultancy contract to support development of Decoy's Designable Multi-Antiviral (D-MAV) candidates "..highlights breadth of expertise available through hVIVO’s integrated platform" novuscomms.com/2026/06/01/hv…
4
6
262
#ELEG Electric Guitar Subscription Update & TVR Awaiting receipt of all funds from May 5th fundraise before issuing investment shares. Issued share capital remains at 2,749,991,691 shares novuscomms.com/2026/06/01/el…
3
3
126
#HVO @hVIVO_UK - Grant of awards - Awarded 10,159,068 options under the hVIVO Long Term Incentive Plan 2024 to certain senior management. - The award is over ordinary shares of £0.001 ("Ordinary Shares") in the form of options novuscomms.com/2026/05/29/hv…
2
2
71
Novus Comms retweeted
May 21
Following #WorldClinicalTrialsDay, how can human challenge trials advance RSV research? Andrew Catchpole (hVIVO) shares how they enable: • Faster, controlled insights • Deeper disease understanding • Early, high‑quality data ▶️ Watch now: eu1.hubs.ly/H0vxHtz0 #RSV #ClinicalResearch #HCT
4
7
598
#HVO @hVIVO_UK - CAPITAL MARKETS DAY -hVIVO will showcase its integrated early clinical development platform at its Capital Markets Day on 11 June 2026 in Canary Wharf, with speakers from Boehringer Ingelheim, RA Capital, ILiAD Biotech and more. read-novuscomms.com/2026/05/20/hv…
6
6
340
#HVO @hVIVO_UK Result of AGM ✅️ All resolutions put to shareholders at the Company’s Annual General Meeting held earlier today were duly passed. novuscomms.com/2026/05/13/hv…
2
2
153
#HVO @hVIVO_UK - Holding(s) in Company - Octopus Investments has increased its shareholding from 12.95% to 13.06% (89,915,858 shares) londonstockexchange.com/news…
4
6
340
Novus Comms retweeted
#HVO - I cover the @hVIVO_UK investment proposition on this week's @StockBoxMedia research talks. youtu.be/k3F9-Yg_alQ
May 11
⏰ Happening tomorrow | 14:00 BST / 15:00 CEST Join Thomas Forst & Esteban Jódar Gimeno to discuss how cardiometabolic trials are moving beyond weight loss toward outcomes that matter. Register now (live on‑demand): [Link] #Webinar #Cardiometabolic eu1.hubs.ly/H0t_XZ00
5
7
315
Novus Comms retweeted
May 11
⏰ Happening tomorrow | 14:00 BST / 15:00 CEST Join Thomas Forst & Esteban Jódar Gimeno to discuss how cardiometabolic trials are moving beyond weight loss toward outcomes that matter. Register now (live on‑demand): [Link] #Webinar #Cardiometabolic eu1.hubs.ly/H0t_XZ00
1
5
9
763
Novus Comms retweeted
#KDNC - In this interview clip with @CadenceMinerals CEO Kiran Morzaria, @Alan__Green asks whether ✅ Forecasts for Azteca profits of $40/t are still in line ✅ Impact of Iran War on shipping costs etc #azteca #amapa #ironore #brazil Full interview here: youtu.be/gWzWNTsr4xQ
#KDNC @CadenceMinerals - CEO Kiran Morzaria and @Alan__Green discuss the latest developments at Amapa, including the award of the Installation Licence for Azteca and Amapa. ✅ Cadence now moving from planning to putting engineers on the ground preparing Azteca for restart at the end of June ✅ Impact of Iran War and closing of the Strait of Hormuz on global markets. Resilience of the iron ore price. ✅ Wider Amapa picture and funding ✅ Sonora Lithium Project - LCM Funding have provided non-dilutive funding to prosecute the Mexican Government ✅ Near term milestones #ironore #Amapa #Azteca #Brazil Watch: youtu.be/gWzWNTsr4xQ
9
12
1,214
Novus Comms retweeted
New £6 million Influenza HCT contract signed! We're pleased to announce a Clinical Trial Agreement with a clinical-stage biotechnology company to conduct a Phase 2a influenza human challenge trial evaluating an investigational monoclonal antibody. 🧑‍🔬 Healthy participants to be recruited by our patient recruitment arm, @FluCamp 🔬 All virology lab work conducted in-house at Canary Wharf 📊 Revenue to be recognised across 2026 & 2027, strengthening our financial visibility This contract demonstrates continued demand for HCT capabilities and reinforces our position as a trusted clinical development partner for innovative biopharma companies. Read full announcement here: eu1.hubs.ly/H0v5m6K0 #HVO #hVIVO #Contract #Influenza #HCT#Phase2 #ClinicalTrial #CanaryWharf #CHIM #Investors
6
11
390